Recently, Gan Gan Medical Technology Jiangsu Co., Ltd., a subsidiary of China Pharmaceutical City, obtained a medical device production license issued by the Jiangsu Provincial Drug Administration. Its production scope includes Class II 14-01 injection and puncture instruments.
Gangan Medical Technology Jiangsu Co., Ltd. settled in China Pharmaceutical City in February 2017 and is committed to the research and development and transformation of related products in the field of blood sugar control. Currently, it has built two production lines, including a pre filled injection pen assembly line and a disposable insulin pen needle injection molding assembly line. The pen type insulin injector developed by the company has obtained a Class II medical device registration certificate. In the future, the research and marketing plan will gradually expand to three major systems: sterile consumables mainly for injection puncture instruments, diagnostic reagents mainly for blood glucose monitoring, and active devices mainly for POCT (instant detection) instruments. We strive to become a high-tech, innovative, and professional high-end medical device production enterprise.
As of now, 97 medical device manufacturing enterprises in China Pharmaceutical City have obtained production licenses, including 32 in vitro diagnostic reagent enterprises and 65 non in vitro diagnostic reagent enterprises, becoming an important gathering area for medical device research and development and production in our province.
